# LXA: Tissue Graft Of 6mm And Greater

- Device class: 3; regulation: 21 CFR —; FDA's rule: PMA required
- FDA decisions: 4
- Recalls: 3 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 2015: 1
- 2016: 2
- 2017: 1
- 2018: 6
- 2020: 1
- 2022: 1
- 2023: 4
- 2024: 3
- 2025: 1
- 2026: 2

## Most-cited predicates

Source page: https://510kreport.com/product-code/LXA
Data by year (CSV): https://510kreport.com/product-code/LXA.csv